FY2025 · period end Dec '25 · from the 10-K filed Feb 12, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $14.09B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000950103-26-007181 | May 12, 2026 | May 14, 2026 | May 14, 2026 13:30 UTC | EDGAR |
| 8-K | 0000277948-26-000013 | Apr 22, 2026 | Apr 22, 2026 | Apr 22, 2026 20:01 UTC | EDGAR |
| 10-Q | 0000277948-26-000014 | Mar 31, 2026 | Apr 22, 2026 | Apr 22, 2026 20:02 UTC | EDGAR |
| 10-K | 0000277948-26-000006 | Dec 31, 2025 | Feb 12, 2026 | Feb 12, 2026 21:14 UTC | EDGAR |
| 8-K | 0000277948-26-000003 | Jan 22, 2026 | Jan 22, 2026 | Jan 22, 2026 21:01 UTC | EDGAR |
| 8-K | 0000950103-25-013783 | Oct 29, 2025 | Oct 29, 2025 | Oct 29, 2025 12:35 UTC | EDGAR |
| 8-K | 0000950103-25-013592 | Oct 20, 2025 | Oct 23, 2025 | Oct 23, 2025 21:15 UTC | EDGAR |
| 8-K | 0000950103-25-013519 | Oct 20, 2025 | Oct 22, 2025 | Oct 22, 2025 20:08 UTC | EDGAR |
Direct links to SEC EDGAR. CSX has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Operating Income (Loss)·Q1 2017
Notable restatementwas$712M
Revised up in a 10-K.
Net Income (Loss) Attributable to Parent·Q1 2012
Notable restatementwas$449M
Revised up in a 10-K. Any P/E built on the original was 6.7% too high.
Operating Income (Loss)·Q1 2012
Notable restatementwas$856M
Revised up in a 10-K.
Net Income (Loss) Attributable to Parent·3 months to Dec 2011
Notable restatementwas$457M
Revised up in a 10-K. Any P/E built on the original was 5.4% too high.
Operating Income (Loss)·3 months to Dec 2011
Notable restatementwas$841M
Revised up in a 10-K.
Net Income (Loss) Attributable to Parent·Q3 2012
Notable restatementwas$455M
Revised down in a 10-K. Any P/E built on the original was 4.1% too low.
CSX is not the only one.
See every restatement we've found across the market — or get an alert the next time CSX revises a number.
Restatements are detected by comparing every vintage of a fact across all of CSX CORP's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CSX's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling CSX CORP — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on CSX yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on CSX and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $14.66B |
| $14.85B |
| $12.52B |
| Gross Profit | — | — | — | — | — |
|---|
| Operating Income | $4.52B | $5.25B | $5.50B | $5.95B | $5.59B |
|---|
| Net Income | $2.89B | $3.47B | $3.67B | $4.11B | $3.78B |
|---|
| EPS (Diluted) | $1.54 | $1.79 | $1.82 | $1.92 | $1.68 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $43.68B | $42.76B | $42.20B | $41.68B | $40.53B |
| Total Liabilities | $30.52B | $30.26B | $30.23B | $29.21B | $27.03B |
| Stockholders' Equity | $13.16B | $12.51B | $11.98B | $12.47B | $13.45B |
| Cash & Equivalents | $0.67B | $0.93B | $1.35B | $1.93B | $2.24B |
| Total Debt | $18.16B | $17.90B | $17.98B | $17.90B | $16.18B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.61B | $5.25B | $5.51B | $5.53B | $5.10B |
| Capital Expenditures | $2.90B | $2.53B | $2.26B | $2.11B | $1.79B |
| Free Cash Flow | $1.71B | $2.72B | $3.26B | $3.41B | $3.31B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | 0.3% | 0.4% | 0.4% | 0.4% | 0.4% |
| Net Margin | 0.2% | 0.2% | 0.3% | 0.3% | 0.3% |
| Return on Equity | 22.5% | 28.3% | 30.0% | 31.7% | 28.5% |
| Return on Assets | 6.7% | 8.2% | 8.7% | 10.0% | 9.4% |
| Debt / Equity | 1.38× | 1.43× | 1.50× | 1.44× | 1.20× |
